Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

Mark for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) concurrently with immune checkpoint inhibitors or docetaxel who ...

"Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer," said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...

Northwestern Medicine scientists have uncovered how a testis-specific protein contributes to tumor growth and progression in ...

What exactly is zero-stage lung cancer? Zero-stage lung cancer, also called Stage 0 NSCLC (Non-Small Cell Lung Cancer) or carcinoma in situ, is the earliest form of lung cancer. At this point ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

The following is a summary of "Prediction of radiosensitivity in non-small cell lung cancer based on computed tomography and tumor genomics: a multiple real-world cohort study," published in the April ...

An independent data monitoring committee has determined that the HARMONi-6 trial for the first-line treatment of advanced squamous non-small cell lung cancer (NSCLC) has met its primary endpoint ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...